在吸烟引起的COPD中,METTL16通过调节谷氨胺代谢来控制呼吸道炎症
Xinyu Jia1, Shan Liu2, Chunan Sun2
1Department of Respiratory Medicine, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, China; Department of Respiratory and Critical Care Medicine, the First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
Ecotoxicology and environmental safety
|December 12, 2024
概括
甲基转移酶METTL16在慢性阻塞性肺病 (COPD) 中降低. 它的缺乏会使炎症恶化,强调METTL16和谷氨酸作为吸烟引起的COPD的潜在治疗方法.
科学领域:
- 肺部医学 肺部医学
- 分子生物学分子生物学
- 表观遗传学 在表观遗传学中,表观遗传学是指表观遗传学.
背景情况:
- 慢性阻塞性肺病 (COPD) 的特点是持续的呼吸道炎症,通常与像香烟烟雾 (CS) 这样的环境污染物有关.
- 甲基转移酶METTL16与各种疾病有关,但其在吸烟引起的COPD中的作用尚不清楚.
研究的目的:
- 调查METTL16在吸烟引起的COPD病变中的作用.
- 确定METTL16影响COPD发展的分子机制.
主要方法:
- 从COPD吸烟者和CS暴露的小鼠和细胞模型的肺组织中分析METTL16水平.
- 使用甲基化RNA免疫沉降测序 (meRIP-seq),RNA测序 (RNA-seq) 和代谢分析.
- 研究了METTL16缺乏和谷氨酸补充剂在CS诱导的COPD模型中的影响.
主要成果:
- 在COPD吸烟者的肺组织和实验模型中,METTL16水平显著下降.
- METTL16缺乏症加剧了CS诱导的气道炎症.
- METTL16调节了谷氨酸-氧酸转胺酶2 (GOT2) 稳定性和谷氨酸代谢,影响了肺上皮层线粒体功能.
- 谷氨酸补充剂在COPD小鼠模型中降低了炎症.
结论:
- 在吸烟引起的COPD的发展中,METTL16/GOT2/Glutamine轴起着至关重要的作用.
- METTL16和谷氨胺是治疗慢性呼吸道炎症的潜在治疗点.
相关概念视频
01:20Chronic Obstructive Pulmonary Disease-II: Pathophysiology
2.7K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
2.7K
01:20Asthma: Pathogenesis and Management
350
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
350
01:17Drugs Used in Lower Respiratory Disorders: Overview
349
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
349
01:26COPD: Management Using Bronchodilators and Corticosteroids
178
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
178
01:25Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
237
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
237
01:26Asthma-II: Pathophysiology and Classification
2.6K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
2.6K